Fundraising Fox

Rex Health Ventures

Corporate VC

Raleigh · Seed–Series B · 4 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Rex Health Ventures is a venture capital firm that invests in healthcare companies and technologies. The firm focuses on early-stage to growth-stage healthcare ventures.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series B
Check
$250K – $500K
HQ
Raleigh, North Carolina, US
Instruments
Equity
Founded
2012
AUM
$10M
Tracked investments
28

Team · 4 people

from the firm's website & public directories
Austin Brooks· Portfolio Manager, Rex Health Venturesin

What they invest in

from 18 of 28 portfolio companies

Healthtech ×15Medical Devices ×7Biotech ×6Digital Health ×5Enterprise Software ×5SaaS ×4Cybersecurity ×2Advanced Manufacturing ×1

HQs:United States×14

Investments · 28 tracked

founders shown can be your intro path

By year:2023 · 22020 · 12017 · 12016 · 12015 · 16 dated

Arrivobioarrivobio.comin✓ verified

Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.

BiotechMedical Devices

Co-investorsOrlando Health VenturesSolas BioVentures

Aerial BioPharma

Development-stage biopharmaceutical company focused on CNS biologics and small molecules.

Arrivo BioVenturesNov 2023

BiotechMorrisville, US

Karen Adams(Executive Officer)Stephen E. Butts(Executive Officer)

AwarepointinJun 2017

Real-time asset tracking and workflow monitoring in healthcare

San Diego, US

Brandon Hull(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)Emily Wilson(Executive Officer)Paul Wallace(Director)Dana Mead(Director)

Co-investorsIcon VenturesHERITAGE HEALTHCARE INNOVATIONKleiner PerkinsNew Leaf Venture PartnersVenrock

Baebiesbaebies.comin𝕏

Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.

BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US

Vamsee Pamula(Executive Officer, Director)inRichard M. West(Executive Officer, Director)in

BoardDennis Sacha(Director)William A. Hawkins(Director)

Co-investorsDuke Capital PartnersIAG Capital PartnersSolas BioVenturesVentureSouth

Bardybardydx.cominAcquired

BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.

Digital HealthHealthtechMedical DevicesSeattle, US

Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)

Co-investorsAPERTURE Venture PartnersAphelion CapitalAscension VenturesLumira VenturesRC CapitalSV Health Investors+1 more

Bio 54
BioStable Science & EngineeringFeb 2020

Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.

Austin, US

John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)

Censinetcensinet.cominJan 2023 · $9M

Censinet provides risk management solutions for healthcare organizations, built by former healthcare operators and security experts who understand the integrated risks healthcare systems face.

CybersecurityEnterprise SoftwareHealthtechSaaSBoston, US

Co-investorsBallad VenturesExcelerate Health VenturesHLM Venture PartnersMemorialCare Innovation FundSchooner CapitalExcel Venture Management+1 more

CenTrakcentrak.comin𝕏

CenTrak provides Real-Time Location System (RTLS) technology for healthcare facilities, including IoT wearables, infrastructure devices, software, and integrations with systems like EMR, CMMS, and Nurse Call.

HealthtechIoTMedical Devices

Co-investorsIcon Ventures

Corcymbiostable-s-e.com

Co-investorsLouisiana Funds

Emergo Therapeuticsemergotherapeutics.comin

Emergo Therapeutics develops drugs designed to modulate inflammatory responses by reducing the production and secretion of inflammatory cytokines, targeting damaging symptoms across a range of diseases.

BiotechHealthtechDurham, US

Robin Hyde-DeRuyscher(Founder)inMoise Khayrallah(CEO)inMargaret Powell(Director)Robert Helmedag(Director)John E. Bailey, Jr.(Director)

Co-investorsWolfpack Investor NetworkHatteras Venture Partners

Gauss Surgicalgausssurgical.com

HealthtechLos Altos, US

Siddarth Satish(Executive Officer, Director)Milton B. McColl(Executive Officer, Director)Ralph L. Arnheim III(Executive Officer)

BoardJay Watkins(Director)inMark Gonzalgo(Director)

Co-investorsCorewell Health VenturesPromus VenturesSonder CapitalSUMMATION HEALTH VENTURES

Jazz Pharmaceuticaljazzpharma.comin𝕏

Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.

BiotechHealthtech

Co-investorsLongitude CapitalProspect Venture PartnersSolas BioVentures

Kit Checkkitcheck.comin

Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.

AI & Machine LearningEnterprise SoftwareHealthtechWashington, US

Kevin MacDonald(Executive Officer)Timothy Kress-Spatz(Executive Officer)

Co-investorsEaston CapitalKaiser Permanente VenturesLionBirdNew Leaf Venture PartnersRock Health

Leitersleiters.comin

Leiters Health is an FDA-registered 503B outsourcing facility that produces sterile compounded preparations for hospitals, surgery centers, and ophthalmic use.

BiotechHealthtechMedical DevicesDenver, US

Co-investorsCorewell Health VenturesEscalate Capital PartnersFrazier Healthcare PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersKaiser Permanente Ventures+2 more

Midnight Pharma

Early-stage biopharmaceutical company developing a novel treatment for insomnia.

NVPnvp.com
Phononic
Phyndphynd.comin𝕏acquired by symplr

symplr Directory centralizes and governs provider data across healthcare organizations, helping health plans and health systems maintain accurate, compliant provider information for credentialing, claims, and member-facing systems.

Digital HealthEnterprise SoftwareHealthtechSaaS

Co-investorsGreen Park & Golf VenturesBessemer Venture PartnersWellington Management

Pryon
Read the Press Releasestryker.com

Stryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers.

Advanced ManufacturingHealthtechMedical Devices

Kevin Loboin

Co-investorsGefinor CapitalLumira VenturesNew Enterprise Associates (NEA)Windham Capital Partners

Rediscovery
Reprieve Cardiovascularreprievecardio.com

Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients.

Digital HealthHealthtechMedical DevicesMilford, US

Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)Mark Pacyna(Executive Officer, Director)inJim Dillon(Executive Officer, Director)Hanson S. Gifford III(Director)Gregory W Mann(Executive Officer)

Co-investorsArboretum VenturesLightstone VenturesDeerfield Management CompanyGenesis Venture CapitalSante Ventures

Symplrsymplr.comin𝕏

Symplr provides an operations platform that consolidates workforce, provider, quality, and financial management workflows for healthcare systems.

Digital HealthEnterprise SoftwareHealthtechSaaS

Co-investorsCharlesbank Capital PartnersFrancisco Partners

Target PharmaSolutionsinJan 2016

HealthtechChapel Hill, US

Margaret Powell(Executive Officer, Director, Promoter)Michael Fried(Executive Officer, Director, Promoter)

BoardMoise Khayrallah(Director)

Thoma Bravothomabravo.comin𝕏

Thoma Bravo is a software-focused private equity investment firm that acquires and invests in enterprise software and technology companies.

CybersecurityEnterprise SoftwareSaaS

Orlando Bravo(Founder and Managing Partner)Carl D. Thoma(Founder and Managing Partner)

Veran Medicalveranmedical.comSep 2015Acquired

St.

HealthtechSt. Louis, US

Mark W. Hunter(Executive Officer)Troy L. Holsing(Executive Officer)Scott Wrightstone(Executive Officer)Maureen Oehler(Executive Officer)Jason Pesterfield(Executive Officer, Director)Ryan Denney(Executive Officer)

Co-investorsRC CapitalVensana Capital

Exits · 1

IPOs and acquisitions across the tracked portfolio

Phyndacq. by symplr

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Rex Health Ventures made?
Rex Health Ventures has 26 tracked investments, 1 of which have exited via acquisition or IPO.
What stage does Rex Health Ventures invest at?
Rex Health Ventures invests at the Seed, Series A, Series B stages.
What is Rex Health Ventures's typical check size?
Rex Health Ventures typically writes checks of $250K – $500K.
What sectors does Rex Health Ventures focus on?
Rex Health Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Rex Health Ventures located?
Rex Health Ventures is headquartered in Raleigh, US.
Who does Rex Health Ventures co-invest with?
Rex Health Ventures most often shares deals with Corewell Health Ventures, Icon Ventures, Kaiser Permanente Ventures, among 34 tracked co-investors.

Media · Podcasts & interviews

featuring the team

The MedTech Startup Podcast - Anita Watkins - Rex Health Ventures

The MedTech Startup · Anita Watkins

Similar investors

Featured in lists